| Literature DB >> 33448695 |
Carlos A Camargo1, Adrian R Martineau2.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has focused attention on the potential role of vitamin D supplementation to prevent COVID-19. In this issue, Merzon and colleagues report epidemiologic data on the vitamin D status of 7807 individuals and their risk of developing COVID-19. In multivariable analyses, low vitamin D status was associated with increased risk of both COVID-19 infection and hospitalization. The authors call for clinical trials of vitamin D supplementation. In this Commentary, we discuss some of the challenges of vitamin D research and provide recommendations for the design of randomized controlled trials of vitamin D supplementation to prevent COVID-19.Entities:
Keywords: COVID‐19; clinical trial; randomized controlled trial; vitamin D
Year: 2020 PMID: 33448695 DOI: 10.1111/febs.15534
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542